Skip to content
bd@cod-research.com
+91 79 6947 8900
+1(732) 749-7719
Request for Proposal
About Us
Our Services
Clinical Development
Global Clinical Operations
Project Management
Global Regulatory
Regulatory Services
Biometrics
Clinical Trial Data Management
Biostatistics
Global Pharmacovigilance
Medical Information Solutions
ICSR & Literature Support
Medical Safety (Aggregate, Signal, Risk Management)
PSMF & Global QPPV Solutions
Clinical Safety & AE/SAE Management Solutions
MedTech Safety
Quality Assurance
Good Clinical Practice (GCP)
Good Pharmacovigilance Practice (GVP)
Our Expertise
Therapy Areas
Specialties
Softwares
aRMM TREx
Insights & Resources
Blogs & Whitepapers
Case Studies
Brochures & Flyers
Webinars & Podcasts
COD Newsroom
Newsletter
Events & Conferences
Event Insights
Press Releases
COD Photo gallery
Careers
Contact Us
For Business Enquiries
For Conference Meetings
Connect with Experts
About Us
Our Servcies
Clinical Development
Global Clinical Operations
Project Management
Global Regulatory
Regulatory Services
Biometrics
Clinical Trial Data Management
Biostatistics
Global Pharmacovigilance
Medical Information Solutions
ICSR & Literature Support
Medical Safety (Aggregate, Signal, Risk Management)
PSMF & Global QPPV Solutions
Clinical Safety & AE/SAE Management Solutions
MedTech Safety
Quality Assurance
Good Clinical Practice (GCP)
Good Pharmacovigilance Practice (GVP)
Our Expertise
Therapy Areas
Specialties
Softwares
aRMM TREx
Insights & Resources
Blogs & Whitepapers
Case Studies
Brochures & Flyers
Webinars & Podcasts
COD Newsroom
Newsletter
Events & Conferences
Event Insights
Press Releases
COD Photo gallery
Careers
Contact Us
For Business Enquiries
For Conference Meetings
Connect with Experts
Insights & Resources
Home
|
Insights & Resources
Clinical Trials
Pharmacovigilance
Regulatory
Corporate Presentation
Quality Assurance
Blog
The Evolution of PRO Collection: From Paper Diaries to ePRO Systems
Read More
Transforming Complexity into Success: A Large-Scale Global Phase III Biosimilar Dermatology Trial
Read More
Flyer
Biometrics
Read More
Flyer
Clinical Services
Read More
Flyer
CT Quality Assurance
Read More
Flyer
Medical Affairs
Read More
Article
Pulmonary Disease Introduction: Prevalence, Causes, Prevention & Treatment
Read More
Blog
Strategic Planning for Patient Recruitment
Read More
EMA
FDA
MHRA
Programme of the 2026 annual meeting of the European network of paediatric research at EMA (EnprEMA)
Source: EMA
Published on 2026-09-18
Summary of opinion: Enhertu, 17/09/2026 Positive
Source: EMA
Published on 2026-09-18
Programme of the 2026 annual meeting of the European network of paediatric research at EMA (EnprEMA)
Source: EMA
Published on 2026-09-18
MedDRA important medical event terms list - version 29.1
Source: EMA
Published on 2026-09-18
User safety for pharmaceutical veterinary medicinal products - Scientific guideline
Source: EMA
Published on 2026-09-18
Organisation chart: Human Medicines
Source: EMA
Published on 2026-09-18
Read More
FDA approves pembrolizumab for adenocarcinoma
Source: FDA
Published on 2025-04-08
Approved Drug Products with Therapeutic Equivalence Evaluations (Orang
Source: FDA
Published on 2025-04-08
Additions/Deletions for Prescription and OTC Drug Product Lists
Source: FDA
Published on 2025-04-08
Recalls small number of acne products for benzene contamination
Source: FDA
Published on 2025-04-08
FDA Drug Shortages
Source: FDA
Published on 2025-04-08
FDA Drug Shortages
Source: FDA
Published on 2025-04-08
Read More
Radiofrequency (RF) Safety Considerations for Wireless Cardiotocography (CTG) Monitoring Systems (DSI/2026/012)
Source: MHRA
Published on 2026-09-17
Class 4 Medicines Defect Notification: Martindale Pharmaceuticals Ltd, Clobazam Martindale Pharma 5 mg/5 mL and 10 mg/5 mL Oral Suspension 150ml, EL(26)A/38
Source: MHRA
Published on 2026-09-17
National Patient Safety Alert: Patient hoists and slings (all types): risk of death and serious harm from falls (NatPSA/2026/005/MHRA)
Source: MHRA
Published on 2026-09-16
Field Safety Notices: 7 September to 11 September 2026
Source: MHRA
Published on 2026-09-14
Field Safety Notices: 31 August to 4 September 2026
Source: MHRA
Published on 2026-09-09
Field Safety Notices: 24 to 28 August 2026
Source: MHRA
Published on 2026-09-03
Read More